Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case seriesBMJ, 2020-02, Vol.368, p.m606-m606 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2020 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m606 ;PMID: 32075786Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyScience, 2021-02, Vol.371 (6531) [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abf4830Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activityJournal of virology, 2014-04, Vol.88 (8), p.4251-4264 [Peer Reviewed Journal]Copyright © 2014, American Society for Microbiology. All Rights Reserved. 2014 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.03571-13 ;PMID: 24478444Full text available |
|
4 |
Material Type: Article
|
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusionProceedings of the National Academy of Sciences - PNAS, 2020-12, Vol.117 (50), p.32105-32113 [Peer Reviewed Journal]Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Dec 15, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2012197117 ;PMID: 33239446Full text available |
|
5 |
Material Type: Article
|
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate modelScience, 2020-05, Vol.368 (6494) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abb7314Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in miceScience, 2021-08, Vol.373 (6558) [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abi4506Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoVScience, 2020-05, Vol.368 (6491) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abb7269Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus InfectionThe Journal of immunology (1950), 2017-05, Vol.198 (10), p.4046-4053 [Peer Reviewed Journal]Copyright © 2017 by The American Association of Immunologists, Inc. ;Copyright American Association of Immunologists May 15, 2017 ;ISSN: 0022-1767 ;EISSN: 1550-6606 ;DOI: 10.4049/jimmunol.1601896 ;PMID: 28373583Full text available |
|
9 |
Material Type: Article
|
Broad neutralization of SARS-related viruses by human monoclonal antibodiesScience, 2020-08, Vol.369 (6504) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc7424Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Protease-Mediated Enhancement of Severe Acute Respiratory Syndrome Coronavirus InfectionProceedings of the National Academy of Sciences - PNAS, 2005-08, Vol.102 (35), p.12543-12547 [Peer Reviewed Journal]Copyright 1993/2005 The National Academy of Sciences of the United States of America ;Copyright National Academy of Sciences Aug 30, 2005 ;Copyright © 2005, The National Academy of Sciences 2005 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.0503203102 ;PMID: 16116101Full text available |
|
11 |
Material Type: Article
|
Contributions of the Structural Proteins of Severe Acute Respiratory Syndrome Coronavirus to Protective ImmunityProceedings of the National Academy of Sciences - PNAS, 2004-06, Vol.101 (26), p.9804-9809 [Peer Reviewed Journal]Copyright 1993/2004 The National Academy of Sciences of the United States of America ;2004 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.0403492101 ;PMID: 15210961Full text available |
|
12 |
Material Type: Article
|
TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike ProteinJournal of Virology, 2014-01, Vol.88 (2), p.1293-1307 [Peer Reviewed Journal]Copyright © 2014, American Society for Microbiology. All Rights Reserved. 2014 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.02202-13 ;PMID: 24227843Full text available |
|
13 |
Material Type: Article
|
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?International journal of epidemiology, 2020-06, Vol.49 (3), p.717-726 [Peer Reviewed Journal]The Author(s) 2020; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association 2020 ;The Author(s) 2020; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association. ;ISSN: 0300-5771 ;EISSN: 1464-3685 ;DOI: 10.1093/ije/dyaa033 ;PMID: 32086938Full text available |
|
14 |
Material Type: Article
|
Inhibition of NF-κB-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases SurvivalJournal of Virology, 2014-01, Vol.88 (2), p.913-924 [Peer Reviewed Journal]Copyright © 2014, American Society for Microbiology. All Rights Reserved. 2014 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.02576-13 ;PMID: 24198408Full text available |
|
15 |
Material Type: Article
|
Cytokine release syndrome in severe COVID-19Science, 2020-05, Vol.368 (6490) [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.sciencemag.org/coronavirus-research-commentary-and-news?intcmp=ghd_cov ;DOI: 10.1126/science.abb8925Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infectionJournal of virology, 2014-10, Vol.88 (19), p.11034-11044 [Peer Reviewed Journal]Copyright © 2014, American Society for Microbiology. All Rights Reserved. ;Copyright © 2014, American Society for Microbiology. All Rights Reserved. 2014 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.01505-14 ;PMID: 25056892Full text available |
|
17 |
Material Type: Article
|
Remdesivir against COVID-19 and Other Viral DiseasesClinical microbiology reviews, 2020-12, Vol.34 (1) [Peer Reviewed Journal]Copyright © 2020 American Society for Microbiology. ;Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology ;ISSN: 0893-8512 ;EISSN: 1098-6618 ;DOI: 10.1128/cmr.00162-20 ;PMID: 33055231Full text available |
|
18 |
Material Type: Article
|
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanismsScience, 2020-12, Vol.370 (6521) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0036-8075 ;ISSN: 1095-9203 ;EISSN: 1095-9203 ;DOI: 10.1126/science.abe9403Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Awake prone positioning in COVID-19Thorax, 2020-10, Vol.75 (10), p.833-834 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.bmj.com/company/legal-information ;This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;ISSN: 0040-6376 ;EISSN: 1468-3296 ;DOI: 10.1136/thoraxjnl-2020-215133 ;PMID: 32546571Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational StudyThe Journal of immunology (1950), 2021-04, Vol.206 (7), p.1569-1575 [Peer Reviewed Journal]Copyright © 2021 by The American Association of Immunologists, Inc. ;Copyright © 2021 by The American Association of Immunologists, Inc. 2021 Copyright © 2021 by The American Association of Immunologists, Inc. ;ISSN: 0022-1767 ;EISSN: 1550-6606 ;DOI: 10.4049/jimmunol.2001126 ;PMID: 33547169Full text available |